Neuregulin-1β通过AKT/mTOR通路抑制自噬减轻脓毒症大鼠骨骼肌萎缩
本研究在大鼠L6肌管细胞和CLP脓毒症SD大鼠中探讨NRG-1β对脓毒症骨骼肌萎缩的作用。脓毒症血清导致自噬相关蛋白ULK1、p-Beclin-1、Beclin-1及LC3B II/I比值升高、p62降低,提示自噬过度激活,同时NRG-1表达下降。外源性NRG-1β通过激活Akt/mTOR抑制自噬、提高细胞活力;PI3K抑制剂LY294002可取消该效应。在CLP大鼠中,NRG-1β同样经Akt/mTOR抑制自噬,增加体重并减轻胫骨前肌萎缩。
要点
- 脓毒症血清处理的L6肌管中自噬相关蛋白ULK1、p-Beclin-1、Beclin-1及LC3B II/I比值升高、p62降低,提示自噬过度激活。
- 外源性NRG-1β通过激活Akt/mTOR信号通路抑制自噬,并提高L6肌管细胞活力。
- PI3K抑制剂LY294002在NRG-1β前30分钟加入可消除NRG-1β的上述效应。
- CLP脓毒症SD大鼠中,NRG-1β经Akt/mTOR抑制自噬,增加体重并减轻胫骨前肌萎缩。
- 该研究为动物与细胞实验,NRG-1β的临床剂量、给药途径与疗程原文未提及,不能直接外推至ICU患者。
适用人群与场景
- L6大鼠成肌细胞经2%胎牛血清分化形成的肌管,分为Con组(正常血清)、Sep组(脓毒症血清)、SN组(脓毒症血清24h后加NRG-1β孵育48h)、血清+NRG-1β+LY294002组(NRG-1β前30min加PI3K抑制剂LY294002)。
- 体内实验使用Sprague-Dawley(SD)大鼠,通过盲肠结扎穿孔(CLP)诱导脓毒症。
诊断标准与关键阈值
- 细胞模型:脓毒症血清处理L6肌管形成脓毒症细胞模型;自噬激活判定为UNC-51 like kinase 1、p-Beclin-1、Beclin-1表达及LC3B II/I比值升高,p62表达降低。
- 动物模型:SD大鼠以盲肠结扎穿孔(CLP)诱导脓毒症。
处置流程与药物剂量
- 细胞实验:L6肌管在脓毒症血清处理24h后加入NRG-1β孵育48h;LY294002在NRG-1β前30min加入。
- 动物实验:CLP诱导脓毒症后给予NRG-1β,具体剂量、给药途径、频次和疗程原文未提及。
- 原文未提及NRG-1β在人体中的剂量、给药途径、频次、疗程或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:细胞实验(L6大鼠肌管)与动物实验(SD大鼠CLP脓毒症模型);样本量与中心数原文未提及。
- 细胞实验:脓毒症血清使L6肌管自噬相关蛋白UNC-51 like kinase 1、p-Beclin-1、Beclin-1表达及LC3B II/I比值升高、p62降低,NRG-1表达下降;外源NRG-1β激活Akt/mTOR抑制自噬并提高细胞活力,LY294002可消除该效应。
- 动物实验:CLP脓毒症SD大鼠中,NRG-1β通过Akt/mTOR通路抑制自噬,增加体重并减轻胫骨前肌萎缩;具体效应量与统计学值原文未提及。
证据类型、等级与局限
- 证据类型:细胞实验与动物实验(非临床研究)。
- 证据等级或推荐强度:原文未提及。
- 局限:仅L6细胞与SD大鼠CLP模型,样本量未报告,NRG-1β剂量与给药方案未明确,结果需进一步临床前及临床研究验证。
对床旁实践的改变
- 该内容为脓毒症骨骼肌萎缩的机制研究,提示NRG-1β/Akt/mTOR/自噬轴可能为潜在干预靶点,但不改变当前急诊/ICU对脓毒症患者的临床处置。
- 适用与不适用人群:原文仅涉及L6大鼠肌管与CLP脓毒症SD大鼠,不涉及人类患者;不能将细胞或动物实验结果直接用于ICU患者。
- 常见陷阱:不能将LY294002(PI3K抑制剂)或NRG-1β的实验性用法当作临床推荐;NRG-1β的人体剂量、给药途径和疗程原文未提及,不可推断。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Several studies have shown that excessive protein degradation is a major cause of skeletal muscle atrophy induced by sepsis, and autophagy is the main pathway participating in protein degradation. However, the role of autophagy in sepsis is still controversial. Previously, we found that neuregulin-1β (NRG-1β) alleviated sepsis-induced diaphragm atrophy through the phosphatidylinositol-3 kinase signaling pathway. Akt/mechanistic target of rapamycin (mTOR) is a classic signaling pathway to regulate autophagy, which maintains intracellular homeostasis. This study aimed to investigate whether NRG-1β could alleviate sepsis-induced skeletal muscle atrophy by regulating autophagy.
METHODS: L6 rat myoblast cells were differentiated using 2% fetal bovine serum into myotubes, which were divided into four groups: Con group treated with normal serum; Sep group treated with septic serum to form a sepsis cell model; septic serum + NRG-1β (SN) group treated with septic serum for 24 h followed by injection with NRG-1β and incubation for another 48 h; and serum+NRG-1β+LY294002 group, in which the PI3K inhibitor LY294002 was added 30 min before NRG-1β, and other treatments were similar to those in SN group. Effects of NRG-1β were also evaluated in vivo using Sprague-Dawley (SD) rats, in which sepsis was induced by cecal ligation and puncture (CLP).
RESULTS: In L6 myotubes treated with septic serum, the expression of autophagy-related proteins UNC-51 like kinase 1, p-Beclin-1, and Beclin-1, and the ratio of LC3B II/I were highly increased, while protein p62 expression was decreased, indicating that autophagy was excessively activated. Moreover, NRG-1 expression was decreased, as detected by confocal immunofluorescence and western blotting. Upon exogenous addition of NRG-1β, autophagy was inhibited by the activation of Akt/mTOR signaling pathway, and cell viability was also increased. These effects disappeared in the presence of LY294002. In SD rats, sepsis was induced by CLP. NRG-1β was shown to inhibit autophagy in these rats via the Akt/mTOR pathway, leading to increased body weight of the septic SD rats and alleviation of atrophy of the tibialis anterior muscle.
CONCLUSION: NRG-1β could alleviate sepsis-induced skeletal muscle atrophy by inhibiting autophagy via the AKT/mTOR signaling pathway.
参考来源
- Yin D, Lin D, Xie Y, et al. Neuregulin-1β Alleviates Sepsis-Induced Skeletal Muscle Atrophy by Inhibiting Autophagy via AKT/mTOR Signaling Pathway in Rats. Shock. 2022. PMID: 34559744. doi:10.1097/SHK.0000000000001860
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。